Explore 2 Growth
1 investments found
Athera Biotechnologies
Athera is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological drugs for treatment of cardiovascular disease.
Funded
SEK 55,095,000
Target
SEK 30,000,000
Capital Target
SEK 60,000,000
Min. Raise
SEK 30,000,000
Percent of Equity Offered
55%
Valuation of equity
SEK 110000000
End Date
21 April 2019